Leading pancreatic cancer researcher is struck off for fabricating dataBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4352 (Published 08 August 2016) Cite this as: BMJ 2016;354:i4352
- Clare Dyer
- The BMJ
A leading researcher into innovative treatments for pancreatic cancer has been struck off the UK medical register for “gross and clear fabrication of research data.”
Thorsten Hagemann, who worked at Bart’s Cancer Institute in London, was found guilty of 24 instances of misleading and dishonest conduct between 2012 and 2014.
He was found to have falsified data in grant applications to the Pancreatic Cancer Research Fund and Cancer Research UK, in a paper published in Nature,1 in another paper which was submitted to Nature Medicine but rejected, and in a presentation to Cancer Research Technology.
Hagemann, who qualified in Germany in 1999, progressed rapidly in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial